Clinical Trial Update: Cytokine-induced Killer Study for Patients With Stage II Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using cytokine-induced killer cells for stage II melanoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Melanoma | Phase 2 | Status: NOT_YET_RECRUITING